Anxiety and depressive disorders in patients with Covid-19

Introduction Coronavirus infection has shown a significant impact not only on physical health but also mental health. Among the long-term consequences in post-COVID period, depressive and anxiety disorders are well observed. A potential mechanism for developing after undergoing SARS-CoV-2 is neuroinflammatory process central nervous system. Objectives This study aimed to discover features of people who suffered from COVID-19. Methods The was conducted October 2021 September 2022 outpatient inpatient conditions S. Korsakov Psychiatric Clinic Sechenov University. 58 patients (17 (29.3%) men 41 (70.7%) women) with diagnosis F32, F34.1, F41-F48.0, or F06.3-06.4 according ICD-10 underwent COVID-19, mainly mild moderate severity (46 (79,3%) (8 (13,8%) consequently), were examined clinically. Results median age among respondents 34 years. Mental illness family history had 38 (65.5%) people. patients, 21 ((36.2%) psychasthenic traits premorbid, 13 (22.4%) – hyperthymic, 9 (15.5%) hysterical. 15 (25.9%) maternal during pregnancy childbirth 16 (27,6%) neurotic childhood, 27 (46.6%) traumatic brain injury general anesthesia. 2 (3.4%) reported substance abuse, 7 (12.1%) abused alcohol. period somatic well-being onset 3 months. duration symptoms disorder treatment psychiatrist main clinical picture impaired concentration (100.0%), decreased productivity (98.3%), sleep (96.6%), mood (89.7%), anhedonia (75.9%), appetite (65.5%), asthenia emotional lability (44.8%), self-blame ideas (43.1%), obsessive thoughts (39.7%), irritability (37.9%), suicidal (19.0%). Conclusions About two-thirds female. reasons consulting concentration, disorders, reduced productivity. In addition, anxiety, asthenia, low revealed, more than half complained apathy. Although depression moderate, level mild, all these accompanied by clinically fatigue. Disclosure Interest None Declared